RECTUM-SPARING PROSTATE RADIOTHERAPY

Welcome to the Brand page for “RECTUM-SPARING PROSTATE RADIOTHERAPY”, which is offered here for Pharmaceutical preparations in the nature of implantable materials, pliable, synthetic hydrogel for medical and surgical purposes; kits that contain the hydrogel and/or polymers that react to form the hydrogel when combined with each other and applicators therefore for use in medical and surgical procedures; and surgical and medical apparatuses and instruments;.

Its status is currently believed to be active. Its class is unavailable. “RECTUM-SPARING PROSTATE RADIOTHERAPY” is believed to be currently owned by “Augmenix, Inc.”